2022 in numbers

2022 has been a promising year for patients suffering from gastroesophageal reflux disease (GERD) as well as clinicians and professionals working in the area of gastrointestinal disease, e-health and artificial intelligence. In May, we launched collaborative eCAP project to make reflux disease diagnostics & care accessible to all, improve patient outcomes and tackle healthcare inefficiencies. As the year is coming to a close, we reflected on the work done.

How did 2022 look in numbers for eCAP consortium?

ü€4.75 million secured in funding from the European Commission through Horizon Europe

ü  9 world-leading experts involved in the project Advisory Committees

ü  12 deliverables submitted

ü  1 work package completed

ü  106+ pages of meeting minutes produced

What is the plan for 2023?

ü  Develop the first eCAP capsule prototype

ü  Meet clinicians and stakeholders in Kenya

ü  Stay curious and keep learning from the cross-disciplinary collaboration between 10 great partners

We wish you healthy and peaceful holidays, a successful end of the year and an even better 2023!